Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors

Isharat Yusuf1, Xiaocui Zhu, Michael G Kharas

  • 1Department of Molecular Biology and Biochemistry, University of California, Irvine, 92697-3900, USA.

Blood
|April 8, 2004
PubMed

Insights

Forkhead Box, class O (FOXO) transcription factors regulate cell cycles. This study shows B-cell receptor signaling inactivates FOXO proteins via PI3K/Akt, crucial for B-cell proliferation and survival.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Forkhead Box, class O (FOXO) transcription factors regulate cell cycle arrest and apoptosis.
  • Mitogenic stimuli activate phosphoinositide 3-kinase (PI3K)/Akt pathways, inactivating FOXO proteins.
  • The role of PI3K-dependent FOXO inactivation in B-lymphocyte proliferation and survival is unclear.

Purpose of the Study:

  • To investigate the importance of PI3K-dependent FOXO inactivation in B-cell cycle progression and survival.
  • To determine if B-cell receptor (BCR) engagement impacts FOXO function through PI3K signaling.

Main Methods:

  • Studied B-cell receptor (BCR) engagement in primary B cells.
  • Investigated PI3K-dependent phosphorylation and nuclear export of FOXO1.
  • Utilized forced expression of PI3K-independent FOXO variants (FOXO1, FOXO3a) in activated B cells.

Main Results:

  • BCR engagement induces PI3K-dependent phosphorylation and nuclear export of FOXO1 in B cells.
  • Forced expression of PI3K-independent FOXO1 or FOXO3a caused G1 cell-cycle arrest.
  • Forced expression of PI3K-independent FOXO variants increased apoptosis in activated B cells.

Conclusions:

  • FOXO inactivation is a critical outcome of PI3K signaling in primary B cells.
  • PI3K-dependent FOXO inactivation is essential for B-lymphocyte cell-cycle progression and survival.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...